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DCI – Denominação Comum Internacional
HU - Hospital	Unit
HCD - Hospital CUF Descobertas
HCIS - Hospital CUF Infante Santo
HCC - Hospital CUF Cascais
HCTV - Hospital CUF Torres Vedras
HCSant - Hospital CUF Santarém
HCS - Hospital CUF Sintra
HCA - Hospital Cuf Almada
CCA - Clínica CUF Alvalade
HCT – Hospital Cuf Tejo
CCB - Clínica CUF Belém
CCM - Clínica CUF Miraflores
CSDR - Clínica CUF São Domingos de Rana
CMFR - Clínica CUF Mafra
CCS - Clínica CUF Sintra
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José de Mello Saúde is inserted in the Portuguese corporate group Grupo José de Mello, which built its first hospital, CUF Infante
Santo, in 1945. Owner of privately held hospitals and clinics that are part of the brand CUF, José de Mello Saúde’s vision is being
the leader in providing health care services, positioning itself in terms of quality and establishing a net of interrelated entities
providing high performance not only in the private sector, but also in the public sector. The company’s mission consists of
promoting health care services based on skills such as knowledge, respect for human life and the environment, thereby developing
intellectual capital and seeking to achieve the best possible result.
José de Mello Saúde nowadays owns 7 hospitals, 2 public-private partnerships, 8 clinics and 1 institute, most of them situated in
the greater Lisbon area. Following the expansion of the health care market, JMS EBITDA increased by 7,72% in comparison to
2015, resulting in an operational result of €41,6 million in 2016 and an operational income of €586,3 million 1. The number of
medical appointments increased by 6,65%, reaching 2207 thousand appointments in 2016. JMS looks forward to expanding its
footprint in Portugal with the creation of a new Hospital in Sintra and the new CUF Tejo. They furthermore inaugurated a new





This consulting project is divided into two related challenges, which can however be separately analyzed:
1. The first challenge consists of a financial analysis of a centralized warehouse for medications. The situation AS IS and TO BE will
be compared with regards to their profitability. Since the previous consulting lab group at José de Mello developed a work on
the centralization of consumables, this challenge will be based on their assumptions and conclusions, bearing in mind that we
are analyzing another product category, which entails other legislative and regulatory issues.
2. The second part of the challenge is to find the best location for the hospital pharmacy. Different scenarios will be analyzed, in
order to identify the most suitable and profitable one for José de Mello Saúde. A possibility of externally selling medications
that had to undergo pharmaceutical processes is incorporated in this scenario.
Deliverables:
• Cost analysis comparing the situations AS IS and TO BE
• Overview of the newly structured pharmacy, explaining which processes are located at which locations: design the blueprint of
the centralized logistics processes and central provisioning of medicines
• Identification of the implications of the new model: regulatory, financial and internal implications






















• As	depicted	below,	in	the	Cluster	Tejo	CUF	Infante	Santo	supplies	CUF	Almada,	CUF	Miraflores and	CUF	Belém,	whereas	CUF	Cascais supplies	
CUF	S.	Domingos de	Rana	and	CUF	Sintra.


















































• Poorly automatized process results in:
Ø Mistakes caused by human interactions
Ø Assistants having to possess deep
knowledge about the delivered
medicines
Ø Long repackaging process
Ø Practical problems when using the
Kanban method
• Decentralized purchasing leads to:
Ø High minimum quantity requirements
set by suppliers and subsequent excess
of stock
Ø High number of purchase orders
• A lack of resources in the purchasing
department leads direct contact between the
pharmacy and suppliers, in order to tackle out-
of-stock situations















































• Reverse logistics does not only entail a high
risk of mistakes due to being highly human
capital intensive, but it is also a protracted
and time-consuming process
• Incongruences emerge with a record of
consumption that is created when the
unitary doses leave the pharmacy.
(Automatically, the charges are transferred
to the client’s bill) However, if there are
changes to the prescriptions, the medicine
is not administered, which leads to
temporary wrong records.
• The personal digital assistants (PDA) do not













































• There are limited resources for
centralized galenic formulation in
terms of human capital and available
space
• The process of galenic formulation
cannot contain any mistake, which
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• What is the current logistical
process and organization of the
technical pharmacy at José de
Mello Saúde?
• Which model assesses the
identified inefficiencies?
• What is the model’s financial
impact?
Warehouse
• Identify and determine all costs in the AS IS
and TO BE scenarios
• Compare the computed costs







• Calculate costs associated to the location of
the centralized galenic formulations process
• Proceed to a recommendation
• Create a holistic scenario
with all the aforementioned
recommendations
• Set up an implementation
strategy
• Assessment of risks and
possible mitigation
• Identify a further




Objective: The main goal of our analysis was to identify gaps and inefficiencies that emerge with the process as it is nowadays. With opportunities for
improvement we were then able to create a holistic recommendation, which addresses the identified problems.
Process
Method: As a first step, we proceeded with a literature review about the processes in a hospital pharmacy, in order to understand each step and gather a
few points of view. The papers already exposed some information about which pharmacy models are more efficient, comparing centralized and
decentralized ones. Furthermore, they describe and define key words, crucial to understand the dynamics of the hospital pharmacies.
The process was sketched after careful on-site observation. The observation took place at the HCIS pharmacy, lead by Dra. Rita Oliveira, as well as at the
HCD Pharmacy, led by Dra. Ana Margarida. The activities were divided into different stages (Reception, Preparation of medication for storage in their unit
doses forms, Order Reception: replacement order, unitary doses prescription, individualized distribution, Distribution) and within each stage every scenario
was taken into consideration. We therefore accompanied every step from the reception of the medicine until the replacement of stock in various sections,
including surgery and admitted patients. The opportunities for improvement were partly identified independently, but we also took into consideration
some opinions we were able to extract from personal interviews. These interviews were conducted with Dra. Ana Margarida (Head of Pharmacy HCD), Dra.
Rita Oliveira (Head of Pharmacy HCIS), Dra. Carla (assistant HCIS) and Dra. Ana (assistant HCD). 3, 4, 5, 6, 7, 8, 9
2.	Methodology
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Objective: Forecast the total area needed for both central warehouse and galenic formulations.
Areas
Method: To forecast the total area needed for this project, we firstly studied the “Manual da Farmácia” from Infarmed. This manual explains which
specific areas are theoretically needed in the warehouse and for galenic formulations, and how much square meters each specific area occupies. The
manual presents a study for a pharmacy serving a total of 500 beds so, to forecast the areas we would need, we divided the total areas in the Manual for
the 500 beds in order to obtain square meters needed/ bed. After that we forecasted the total number of beds JMS might be serving in 2022 and
multiplied that total by the square meters/ bed computed before. Through this method we were able to forecast a total area of 320m" for the CW and 88
m" for galenic formulations. 10
2.	Methodology
Revenues
Objective: Estimate the total revenues generated by setting free areas inside each hospital due to the centralization of the medicines warehouse and
galenic formulations.
Method: To forecast the total revenues generated we asked the Production Department of JMS for information about the size of a doctor’s office;
duration, price and margin of contribution of each appointment. Then, dividing the area set free in each hospital by the size of an office we obtained the
approximate number of offices available in each hospital. Furthermore, we calculated the number of appointments per office per year, using the duration
of each appointment. Finally we computed the accumulated potential profit between 2018 and 2022 by multiplying the number of appointments per year
by price of each appointment, times the margin of contribution.
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Objective: Calculate the costs related with stocks, in both scenarios AS IS and TO BE, to compare both situations, as well as find out the optimal model
that minimizes the holding, ordering and invoice costs, in a period of 5 years.
Stocks
Method: Information from September 2016 to August 2017 regarding all HU of JMS was used, provided by the Pharmacy. This information included the
average stock of March 2016, as well as the entries in all pharmacies during all 12 months. This represents the most recent information available, thereby
being the most correct one to study the current situation of the firm, and correctly make predictions. We calculated the unitary price of each product (since
the price is variable, an average of the price of each product bought was made), the value of annual and daily consumption, number of orders and average
number of product in each order, and finally the number of invoices and the average number of invoices per order. All these dimensions were analyzed
according to the category of each hospital and current number of beds in each category. With this information, by bed and type of hospital, we were able
to make realistic predictions, since we knew how many new hospitals would open in the 5 year time frame, as well as the respective number of beds.
Some other relevant data was provided by JMS: Value of WACC (financial department), and cost with orders and invoices (Logistics Department).
In all models used, three major cost dimensions were compared: total cost of holding stock, total cost of invoices and total cost of orders.
The scenario AS IS was studied taking into consideration the average level of stock in March 2017, since that month represented an average of the level of
stock during the year. The remaining variables relied on data from the entire period.
For the TO BE scenario, different models were used, based on information regarding the entries in the pharmacies. First, models which assumed linear
consumption were computed, having fixed safety stock (SS 2, SS 4 and SS 10). These were used as a way to study the effects of changing certain variables
(more SS will result in higher inventory levels, and lower number of orders). Besides, the Economic Order Quantity (EOQ) model was used, since it
minimizes the sum of Ordering and Holding Costs, while having the capacity to be calculated with and without linear consumption. To study the variance in
consumption, a Safety Stock was calculated, with a service level of 95% and 99%, representing the probability of avoiding stock outs. To do so, a daily
variance for each product was calculated, and the values of the service level were taken from the “Z table”. Finally, a last EOQ model was developed, (EOQ
Safe) where it was assumed a SS of 10 and 7 days, in the first two years respectively, and from that point, a service level of 99%. This model was asked by
the company, since it is more cautious due to the lack of efficiency in the first years of the transition to a central warehouse. 11, 12, 13
For the unitary doses scenarios, since it requires some quantities of stocks in each Point-of-Care, a two day safety stock was added to avoid stock-outs.
2.	Methodology
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Objective: Estimate the 5 year cost of all employees with tasks associated to the pharmacy, in a centralized and non-centralized scenario. Furthermore,
measure potential synergies with workers in other areas, mainly the ones in charge of clinical consumables.
Human	Resources
Method:
Firstly, we acquired the average hourly cost with each worker, according to their function (Technical Director, Pharmacist, Pharmacy
Technician and Medical Assistant). This value was provided by the Human Resources Department.
• AS IS scenario: We were given the number of workers in each HU, per year, by the pharmacy Administration. That information was
used to calculate the current costs with FTE’s associated to the pharmacy. The average of the number of workers per HU category was
computed, to correctly predict the necessary increase in Human Resources during the 5 years.
• TO BE scenario: We divided the number of workers into two areas: The ones in the central warehouse, and the ones in each HU.
1) To calculate the first dimension, the group measured samples of time for each activity (reception, repackaging, storage and
picking), while taking notes of the number of medicines included in each task. Then, with the help of the information
computed in “Stocks”, such as number of receptions and orders, the total time for each task was calculated. To measure
synergies in the warehouse, the group contacted the team working on the centralization of clinical consumables and asked for
the number of HR included in their project and the percentage of time that could still be allocated to pharmacy activities, in
each task. We were then able to identify and compute the synergies.
2) 2) Regarding the workers in each HU, due to the huge logistical variations of each HU, instead of measuring times, a more
general study was performed. Through dialogue with the Technical Directors of the pharmacies of the category A UH’s, we
calculated how many people would be needed in each HU, taking into consideration the efficiency gain and expunged






The difference between having centralized or non centralized Unitary Doses, in a Human Resources dimension, is expressed in the
number of hours that would be spent doing inverse logistics. So, the daily amount of time spent performing this activity was computed in




Objective: Estimate the Total Costs of ESS, which are the costs incurred by the warehouses, for the AS IS situation (one warehouse per hospital) and for
the TO BE situation (only one warehouse for all hospitals). A comparison will then determine the savings or additional costs of having a central warehouse.
In order to calculate the total ESS costs for the Central Warehouse we firstly asked João Costa Macedo for the ESS costs per hospital, who
advised us to use the same costs as the Consumables Project. After gathering all information needed we computed the unitary cost by
dividing the ESS costs of a hospital by its total area. To calculate the AS IS scenario we simply multiplied the unitary costs by the total area
of the hospital, updating the unitary cost for each year using the forecasted inflation rate. To calculate the TO BE scenario, we decided to
use as unitary cost per square meter, the average of ESS unitary costs of all hospitals. Then we followed the same process as in the AS IS





The specific infrastructure, facilities and devices needed for this area have different consumptions of ESS from all other areas within the
CW. Once there is no reliable measurement for the consumption of most of ESS in this area such as water and electricity, we decided to
only include the rent of the required space.
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2.	Methodology
Objective: Forecast the Capex for each scenario analyzed and compare the results.
Method: For the forecast of the CAPEX we had to take into account two different types of CAPEX and apply a different methodology to each one of them.
CAPEX
Within infrastructures and facilities we accounted for costs such as: building up and renovate infrastructures; installation of ventilation
system, fire alarm and sprinklers and air-conditioning. To obtain these values we reached out to the Department of Infrastructures of JMS






The specific devices which we accounted for were: PDAs and shelves for unitary doses and automated packaging machines. To better
estimate the price and characteristics of each product we talked to various suppliers: BIQ (repackaging machine) ,17, Mobit (shelves) 1,




Objective: In sum, the aim was to compare four scenarios, which include the following variables: type of distribution (self-distribution or outsourcing) and
optimal scenario (centralized unitary doses production or decentralized unitary doses production).
Method: When calculating the self-distribution costs, we started by defining the most efficient routes, bearing in mind the distance
between the hospitals and clinics and the frequency of delivery. Coming to the conclusion that a lower frequency would not significantly
increase the cost of stock and CAPEX at each hospital, we decided to deliver to Category A hospitals two times a day, 6 days a week,
Category B hospitals once a day, 5 days a week and deliver to the clinics only 3 times a week. After fixing the routes and their frequency,
we calculated the total time for each route, having included 15 minutes at each stop (time to unload the truck). From there on, we set the
number of trucks and drivers necessary to fulfil all necessary requirements. We assumed a renting contract for the truck with an
associated cost of 1200€ per month, per truck (information provided by IVECO). We then proceeded by computing the gas cost per
kilometre and the tolls associated with each route. With this method, we got to a final cost in terms of gas and tolls per route and the




To estimate the cost of outsourcing the distribution, we made two requests for quotation. One was provided by Corrida do Tempo, the
current distributor at JMS, and the other one by Torrestir. Since the quote provided by Torrestir was much higher than the one provided
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laboratory,	with protection of the
pharmacist and the formulation
Centralized production (JMS)	of
galenic formulation in	sterile





the raw material	that will be
used
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To maintain security, an integrated information system with usage of PDAs, which allows an
easier and faster check and double-check, would make the process more efficient. The final
aim is that the pharmacy assistants do not need to have specific knowledge of the incoming
medicines to check and double-check the orders.
Negotiate with the suppliers, in order for them to place a bar code on each unit doses
(depends on the medicine and format needed) or give higher preference for the suppliers










This is due to: high lead times; limited space for the amount of activity, excessive stock due to
minimum quantity requirements. A centralized purchasing system and warehouse, with
possibility to improve the efficiency of the stock management, would mitigate this issue.
Negotiation with suppliers and / or give higher preference for those who supply the
medication in its optimal format
Analysis of the available machines in the market, and investment in a better option, which











Centralized provisioning and purchasing of medicines
Centralized and continuous provisioning and purchasing of medicines
Digitalization and automation of stock management, by using PDA’s.
Nevertheless, the Kanbans system should remain in function, as a visual support
Introduction of clinical protocols into the information system; POC should be
informed on a monthly basis about the difference between consumption and
prescription, in order to minimize it; Raise awareness among physicians and









Decentralization of the process of preparing the unitary doses (preparation in
each POC for 8, 12 or 24h), simultaneous consumption/billing and
administration record in the moment of the actual administration, will eliminate
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According to	our forecasts,	the CW	will cost JMS	less €~1	295	k	between 2018	and 2022.	This is possible mainly due to	the
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1 2 3Centralized	Purchasing Warehouse	Reception Repackaging	and	Storage
• Centralized provisioning and
purchasing allows for JMS to meet
the minimum quantity
requirements set by suppliers,
thereby reducing excessive stock.
• Negotiations with the suppliers,
due to less complex and frequent
distribution routes, could result in
lower costs.
• Possible synergies between
medicines and consumables could
arise with joint distribution.
• Orders are received and registered by
PDA scanning (prevents manual order
conformity check)
• After scanning, the stock immediately
enters the information system
• A double-check is required (after the
PDA scan, a double-check precedes
the storage)
• There is no need to have deep
knowledge about the products in
order to develop the tasks at the
reception.
• After the repackaging,
the medicines are
stored by batch in
separated shelves.
Each medicine has a
respective destination.
• Serums can be stored




• The whole warehouse














• Cold chamber / Fridge
• This zone is intended for the
preparation of orders, which will be
delivered to each hospital and
clinic.
• When an order is prepared, a
consumption record is created by
scanning the bar code with the
PDA. A sign is placed on the order,
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2017 2018 2019 2020 2021 2022*
Inflation	% 1,6% 1,7% 1,7% 1,8% 1,8% 1,8%
Source:	Programa	de	Estabilidade	2017-2021	- Ministry of Finance29











4 Medicines	Warehouse:	Centralized vs Decentralizedi. Recommendation






































































































AS	IS SS2 SS4 SS10 EOQ	L EOQ	95% EOQ	99% EOQ	Safe









Increase in	costs in	the period of analysis,	2018-2022	(%)
AS	IS SS2 SS4 SS10 L	EOQ	 EOQ	90% EOQ	95% EOQ	Safe































• EOQ has best results, but EOQ Safe was the chosen one due to the existence of
a reasonable SS.
• Fewer costs with EOQ Model due to a higher quantity of average stock than
other models, since the cost of holding stock is inferior to the cost of Purchase
Orders.
• EOQ Safe allows for a reduction of 80% of orders, in comparison to AS IS, and
58% less average stock value.
• In EOQ Safe, inventory costs represent 65% of total costs.
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• Central warehouse allows for earnings with efficiency and quality, basic components of the strategy of JMS: Elimination of duplication
of some tasks, such as reception and storage. Furthermore, the centralization of orders saves time, and finally, there are also earning
in terms of automatization of processes.
• Significant reduction in costs with cut of medical assistants (4 in 2018, 8 in 2022), amounting to a total of €168 thousands (only in
2022, the savings are €48 thousands), but introduction of a Technical Director in central warehouse counterbalances this.
• The number of Pharmacists doesn’t suffer any change because there are no gains or losses in efficiency in their job.
• Synergies equivalent to 12 hours of Medical Assistant work time, in the warehouse. There are synergies in terms of the Technical
















2018 2019 2020 2021 2022 Total





2018 2019 2020 2021 2022
HU 2 2 2 2 2
Warehouse 1 1 1 1 1
HU 18 21 21 21 21
Warehouse 0 0 0 0 0
HU 0 0 0 0 0
Warehouse 1 1 1 1 1
HU 10 11 12 12 12







Total 37 42 43 44 44
2018 2019 2020 2021 2022
Technical	Director 2 2 2 2 2
Pharmacists 18 21 21 21 21
Pharmacy	Technician 1 1 1 1 1
Medical	Assistant 19 22 24 25 27
































































2018 2019 2020 2021 2022
Reception 2,66 3,15 3,33 3,33 3,33
Repackaging 6,87 7,09 10,05 11,35 11,35
Storage 3,17 3,75 3,96 3,96 3,96
Picking 39,49 41,65 43,80 43,80 43,80
Total 52,18 55,63 61,14 62,44 62,44
#	of	workers 6,52 6,95 7,64 7,81 7,81
Rounded	# 7 7 8 8 8
#	of	workers 5,02 5,45 6,14 6,31 6,31


















Technical	Director 1 100% 8
Reception 2 0% 0
Storage 3 20% 4,8
Picking 6 15% 7,2
Clinical	Consumables	Warehouse
2018 2019 2020 2021 2022
Number 2 1 2 1 1
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2017 2018 2019 2020 2021 2022
AS	IS	 310.04 346.52 460.17 481.67 481.67 481.67
2017 2018 2019 2020 2021 2022





2017 2018 2019 2020 2021 2022
HCD 39.89 40.56 41.25 41.27 41.29 41.31
HCIS/	HCT 35.98 36.59 37.21 37.23 37.25 37.26
HCC 33.34 33.91 34.49 34.50 34.52 34.54
HCTV 32.36 32.91 33.47 33.49 33.51 33.53
HCSant 31.50 32.03 32.58 32.60 32.62 32.63
HCSint - 32.95 32.97 32.99 33.01 33.02
HCLeiria - - 33.51 33.53 33.55 33.57







2018 2019 2020 2021 2022
HCD 4 4 4 4 4
HCIS/	HCT 5 9 9 9 9
HCC 1 1 1 1 1
HCTV 2 2 2 2 2
HCSant 2 2 2 2 2
HCSint 1 1 1 1 1
HCLeiria - 1 1 1 1
HCA - - 1 1 1
















2018 2019 2020 2021 2022 Total
HCD 19,269€								 19,596€																		 19,605€											 19,613€								 19,622€								 97,705€									
HCIS/	HCT 21,725€								 39,771€																		 39,790€											 39,809€								 39,828€								 180,923€						
HCC 4,027€											 4,095€																				 4,097€													 4,100€											 4,102€											 20,421€									
HCTV 7,817€											 7,950€																				 7,954€													 7,959€											 7,963€											 39,643€									
HCSant 7,609€											 7,738€																				 7,742€													 7,747€											 7,751€											 38,586€									
HCSint 3,913€											 3,915€																				 3,917€													 3,920€											 3,922€											 19,587€									
HCLeiria - 3,980€																				 3,982€													 3,984€											 3,986€											 15,932€									
HCA - - 3,982€													 3,984€											 3,986€											 11,952€									
Total 64,360€								 87,045€																		 91,070€											 91,115€								 91,160€								 424,750€						
42
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2018 2019 2020 2021 2022
Evolução	Rendas	2018	- 2022
TO	BE AS	IS DELTA
2018 2019 2020 2021 2022 TOTAL
TO	BE 18,896	€ 18,896	€ 18,896	€ 18,896	€ 18,896	€ 94,482	€
AS	IS 31,316	€ 43,901	€ 48,145	€ 48,145	€ 48,145	€ 219,653	€
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2018 2019 2020 2021 2022 2018	-	2022
172,500€			 1,500€				 1,500€				 1,500€				 1,500€				 178,500€				
64,000€					 36,500€		 38,000€		 9,000€				 9,000€				 156,500€				






Since medicines repackaging is done for all hospitals at the Central Warehouse, there is no reason to keep the existing
repackaging machines in the hospitals (HCD & HCIS). Thus, these machines will be transferred to the CW to increase
repackaging capacity together with the new machine. See Appendix A.2.2.5.
• In the AS IS scenario repackaging will be performed in each hospital individually. For that reason each existing
hospital and the ones yet to come will need their own repackaging machines.
• These repackaging machines are cheaper than the one chosen for the CW because they has lower capacity which is
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Point-of-Care Centralized at CW
478	491	€
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The optimal alternative consists of decentralizing the unitary doses,	since its centralization would result in	the duplication










• Tejo (Hospitals category A): Twice a day, 6 times a week
• Norte (Hospitals Category B): Once a day, 5 times a week
• Clinics: Once a day, 3 times a week
The costs of self-distribution include the costs with the necessary
quantity of drivers and the required number of trucks. We assumed a
monthly renting contract of 1200€, which includes the cooling system











Self-distribution 496	880€										 	 943	521€						 	
Outsourcing 495	127€										 	 973	618€						 	
49
5.2.1	Distribution:	Synergies with clinical consumables
The synergy with the distribution of clinical consumables reduces the costs allocated to	the pharmacy (about 75%	of











































2018 2019 2020 2021 2022 Total
SS1 2	407	€ 3	462	€ 3980	€ 4	051	€ 4	124	€ 18	024	€
SS2 4	815	€ 6	923	€ 7959	€ 8	102	€ 8	248	€ 36	047	€
51
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Year 2018 2019 2020 2021 2022
Nr of	HR 0,5 0,5 0,5 0,5 0,5
Value	of	Synergy €	2790 €2837 €2888 €2940 €2993
52
AGENDA






















Double Price Single Price TOTAL















Accumulated value of stuck invoices, in the studied HU from January to
October = €329 k.
60% of this value = approximately €200 k (accumulated value) for issues










The elimination of reverse logistics and billing of the medicine
only when it is administrated to the clients allows for up-to-










i. Flow Diagram and description of the current process




ii. Centralized warehouse and purchasing department
iii. Costs Analysis
5













Galenic Formulation Repackaged medicines	for	galenic formulation























• New	and optimized space
• Release of the total	area of the HCD	pharmacy
• Doesn’t need additional licensing
• Utilization of the area of the pharmacy,	which could
be used for	profitable activities.
It won’t be beneficial	to	make the galenic	formulation	at	the	HCT,	since	the	area	of	the	pharmacy	in	this	HU	can	be	used	for	
other	tasks	and	activities	that	generate	profit.
Galenic Formulation Repackaged medicines	for	galenic formulation

















Galenic Formulation Repackaged medicines	for	galenic formulation
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2017 2018 2019 2020 2021 2022
HCD 39.89€				 40.56€				 41.25€				 41.27€				 41.29€				 41.31€				
HCIS/	HCT 35.98€				 36.59€				 37.21€				 37.23€				 37.25€				 37.26€				
Preço	médio	por	consulta	(euros)
2018 2019 2020 2021 2022
HCD 4 4 4 4 4






2018 2019 2020 2021 2022 TOTAL
HCT 21,196€								 21,556€								 21,565€								 21,575€								 21,584€								 107,476€		
HCD 19,118€								 19,443€								 19,453€								 19,462€								 19,472€								 96,948€					












HCT	(€) 80.21 CW	(€) 59.04
2018 2019 2020 2021 2022 TOTAL
HCT 7,058€				 7,058€				 7,058€				 7,058€				 7,058€				 35,292€		
HCD 9,643€				 9,643€				 9,643€				 9,643€				 9,643€				 48,214€		


























The self-distribution costs, as well as the outsourcing quotations, both include a compulsory first stop at the
HCD, in order to pick up galenic formulations.
If the process of galenic formulation is transferred to the warehouse, the costs of distribution would only
marginally be reduced, since only the Norte route and Clinics route would undergo minor changes. Due to
the short distance between the warehouse and the HCD, these changes would not have a significant impact
on distribution costs.
These costs can therefore be transferred to the optimal scenario and to the case in which galenic
formulation is centralized at the HCD.
The aforementioned quotations include a	compulsory initial stop	at the HCD,	since the production of galenic formulation is













5 pharmacists in total for the galenic
formulation, responsible for:
• Activities of production of formulations
• Validation of medical prescriptions, and
double-check.
• Pharmacists will operate at 100%, so there is
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• Design and prepare the information systems for the
warehouse and the POCs (most probably SAP)
• Investment in more advanced technologies will only be
analysed after stabilizing the activity in the warehouse
• 500 m2 predicted for the pharmacy in the central
warehouse by the infrastructure department
• Various alternatives of warehouses, in Lisbon:
v Forte da Casa 1500 m2, constructions necessary,
activity can start in March 2018
v Other warehouses in Lisbon
Choosing	the	warehouse Information	system
Preparing	the	infrastructures
• Clinical consumables routes will adapt to medication
routes (consumables only need to be delivered once a
day)
• Segregate or join consumable’s and medication’s spaces
and areas (e.g. a cooling area for medicines and
consumables)
• Preparation of each POC (infrastructure and information


















The Infarmed might not concede the necessary licenses, or only part of
them.
Information systems
The information system used at the central warehouse has to be
compatible with the one used at the Hospital Units. If the information flow
between both parties stops or includes mistakes, the service quality might
decrease drastically.
Change Management
Risks emerge with the re-allocation of human resources, adaptation to new
systems and processes.
4 Implementation of Clinical Consumables ProjectTiming and logistical issues of this project have to be combined with theimplementation of the clinical consumables project, which will precede the






The optimal scenario requires two licenses: gross distributor license and production license. If the production license is not
conceded, the centralized galenic formulation will stay at the HCD, while the repackaging can be centralized at one of the hospital
pharmacies. If the distributor license is not conceded, all activity, including storage and repackaging can be centralized into one




A deep analysis on the risks of combining the system in the warehouse and the system in the HU has to be developed, in order to
prevent malfunctioning. Emergency plans have to be created in case of system failure, which would entail a break in information
flow from the warehouse to the pharmacies.
Change	
Management
A change management plan can mitigate the associated risks. The plan should include information about re-allocation of HR and HR
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• Management of documents
• Logistics: technology, automated management
of reception, order preparation and delivery of
products





















i. Flow Diagram and description of the current process




ii. Centralized warehouse and purchasing department
iii. Costs Analysis
5































Although each one of us had from the beginning on really high
performance standards set for themselves, I strongly believe I
supported the group with some perfectionist final aspects, which
equalized performance within the group.
It took me a significant amount of time to understand the processes at
the pharmacy, which is why, throughout the project, it was important
to get some guidance and strategic support from my teammates.
I feel like pressure and stress influence creativity and work quality.
Even though I always worked towards meeting deadlines, what wasn’t
perfectly done in time did not correspond to our quality standards,
thus was only decently presented afterwards.
I believe that within our group, all of us contributed equally with new
and creative ideas, thereby no one occupying this role independently.






Considering myself a very stable, enthusiastic, supporting and
communicative person, I always aimed for unity and harmony within
the group. Creating a good environment is key for satisfaction and
work quality.
Prospector
I consider myself a very open and communicative person. Thereby, I
naturally played a role of PR, taking the initiatives to call or contact
people external to the project and ask for their contribution.
Maintaining those contacts was also in our interest.
“Jessica is a very communicative and open person,
who always tries to create a very good working
environment. She kept in contact with external
contributors, thereby getting constant feedback for
our project. Her detail-oriented attitude added a lot
of value to our project. ”
“Jessica is a dynamic person, full of energy, who
played a key role in the group. She was always really
communicative, helping maintaining a positive
environment in the group, and with other
stakeholders. Her attention to detail and hard work
ethics helped pushing the project forward. I am sure




















After setting major guidelines, I believe I am a very practical person,
who likes to set theory into practice. This project confirmed this
hypothesis, since it required a large amount of practical work, which I
enjoyed every day.
Since I consider myself a very calm person, I never feel an extreme
sense of urgency. I am responsible, which is why I organize myself the
right way, to avoid last-minute pressures.
As I am a very practical person and enjoy working myself, my attention
was not on monitoring my teammate’s work. Furthermore, they made
it pretty simple to trust them completely.
It was hard to be very creative in a topic that was so new to us at the
beginning. Furthermore, the project itself did not give a lot of space




I believe I was able to from early on assimilate a large amount of
information, in short time. Understanding the processes was key to
developing a strategy for our project and setting the main milestones.
Team	
Worker
I am a very stable and communicative person, who is always ready and
eager to help out my teammates. It was of utmost importance to me
to create a nice working environment, so that everyone could work as
efficiently as possible, while enjoying the project and the work. “Duarte filled without doubt the role as strategist in
our team. From early on, he was able to process and
connect all information given and see the big
picture. He provided the guidance to the project,
especially in the beginning, when all ideas were still
vague, while always being an exceptional team
worker. ”
“ Duarte brought his experience and fast and clever
thinking to the group, which helped the other
members feel more at ease, and more confident. His
skills to guide and plan our work were key, and
brought our work to another level. He is an excellent






















I know how to listen and communicate with others, encouraging them
to express themselves freely. I like to be supportive, and build on each
group member ideas. I feel that each member of our group fits in this
category, which makes it increasingly easier to have success.
I am not the most extroverted person, and sometimes I lack some
energy to do certain tasks, mainly related with communicating with
third parties. A good allocations of tasks was key for me to surpass this
problems.
I tend to discard some secondary tasks, such as deadlines or some
planning activities, and focus too much on what needs to be done. The
role of my colleagues was key to help me stay more organized.
I am not too perfectionist in some things I find secondary for the goal
of the project. I noticed that in the later stages of our project, mainly
in the elaboration of the final thesis. I think this is a subject I can




Before making any decision, I like to consider all possible options, and
analyze them critically, so that the optimal solution is achieved.
Besides, I am a stable person, who doesn’t let emotions interfere with
my judgments, which I consider key to success in a work environment.
Operational
As a very stable and balanced personality, I strongly believe I work
methodically and efficiently, in order to create an optimal
organizational frame. I really appreciated putting our projects and
goals into practice. “I would describe Miguel as the operational side of
our team, with major soft skills on how to manage a
harmonic team work. His intellectual capacities
accelerated and contributed significantly to our
project. We really owe him a major part of the
theoretical content of our work.”
“Miguel is the most focused member of our team.
With his enormous analytical capacities and his
extraordinary resilience he is not only a very good
teammate, but also a dear friend. He is a very stable
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6)	Plano	Nacional	de	segurança	na	saúde.Diário da	República,	2ª	série	– N.º28	– 10	de	fevereiro	de	
2015		

































































• Unpicking of medicines
• If the batch and expiry date are written on each unit dose of the medicine, in case of the oral tablets, the blister is cut manually. Afterwards, these
unit doses are stored.
• If the batch and expiry date are not written on each unit dose of the medicine, the medicine is repackaged and a sticker is glued to the package with
the missing information
• If the oral medicines have to be removed from their blisters, they are separately placed in a machine, which will repackage them, one by one. The
expiration date is 6 months and a red sticker is glued to the package to drive the attention of the workers to the short expiration date.
• If the medicines do not have to be removed from the blisters, after cutting the blisters, they’re also inserted in the machine, which will repackage
them.
• In all repackaging cases, the batch, DCI, expiry date, bar code and dose have to be entered into the information system manually
• Double-check of repackaging by pharmacist




• Medication for stock replenishment of POC for the hospital in question: an assistant identifies the consumption in each POC, verifying the quantity of
consumed medication and comparing it to the consumption recorded digitally. Then, a box is prepared with the necessary medication for stock
replenishment.
• The medication is transported to each POC, bearing in mind a weekly schedule for different hospital services.
• If the stock is not for the hospital in question: medication is placed in a box, ready for expedition to another hospital or clinic.
• Before delivery, a record of temperature, humidity, storage and transport conditions is created, so that the process is protocolled.
• Medication for unitary doses (division of medication by client): A drawer in which the prescribed unit doses are inserted for a time span of 8, 12 or
24h, which serves one specific client. The prescription has to be double-checked by a pharmacist.
• These drawers are prepared at the unitary doses area of the pharmacy, afterwards transported to the services/POC, at around 18h (unitary doses are
prepared for the whole next day)
• Continuous analysis of the prescriptions to identify potential changes made to them by physicians.
• If there are changes: prepare the requires medication in the pharmacy and transport it to the POC, changing the content of the drawer in question.
• For any type of distribution, there is always a digital record of consumption in the information system.
Order	Reception:	replacement	order,	unitary	doses	prescription,	individualized	distribution
• Confirmation if there is stock when a prescription order enters the pharmacy .
• If there is no stock, an order is sent to the purchasing department and the pharmacy is informed about the lack of stock.
• It has to be confirmed if the unavailable medication is in stock in either other CUF hospitals or in nearby neighbor hospitals. If possible, borrow the
medicine if there is no substitute in stock.
• If there is stock and the Kanban is visible, an order has to be issued to the purchasing department, and the Kanban should be collected.
• If there is stock and the Kanban is not visible, the medication is distributed (either traditional distribution, individualized or by unitary doses.













• After the prescription order enters the pharmacy, the raw materials that will be used to create the galenic formulation have to be recorded on paper.
• A pharmacist validates the latter step and registers the consumption of the raw materials in the information system.
• There are two types of galenic formulations: sterile and non-sterile.
• The sterile formulations include oncology and parenteral nutrition, which are produced in a centralized way for all CUF hospitals.
• The quality of the formulation has to be controlled by a pharmacist.
• A label is placed on the formulation with the following information: batch, expiry date, expiry date of raw material, composition, quantity, conservation
guidelines, dosage, and vacant spaces to add the name of the client, the physician and the pharmacist.

























m) «Distribuição por grosso»,	atividade de	abastecimento,	posse,	armazenagem ou fornecimento de	medicamentos destinados à	transformação,	revenda ou utilização em serviços médicos,	
unidades de	saúde e	farmácias,	excluindo o	fornecimento ao público;
Artigo 79.º
Aquisição direta de	medicamentos
1	- Os fabricantes,	importadores ou distribuidores por grosso só podem:
a)	Vender	medicamentos diretamente a	farmácias;
b) Vender	medicamentos não sujeitos a	receita médica a	pessoas singulares ou coletivas autorizadas,	por força da	lei,	a	vender	medicamentos ao público;
c)	Transacionar medicamentos livremente entre	si;
d)	Vender	medicamentos a	estabelecimentos e	serviços de	saúde,	públicos ou privados,	e	a	instituições de	solidariedade social	sem fins	lucrativos,	que	disponham de	serviço médico e	
farmacêutico,	bem como de	regime	de	internamento,	desde que	os medicamentos adquiridos se	destinem ao seu próprio consumo e	estes estabelecimentos,	serviços e
instituições se	encontrem devidamente autorizados para	o	efeito pelo INFARMED,	I.P.;
e)	Vender	determinado medicamento a	entidades públicas ou privadas a	quem o	INFARMED,	I.P.,	haja concedido,	por razões fundamentadas de	saúde pública ou para	permitir o	normal	












1	-	O	fabrico,	total	ou parcial,	de	medicamentos no	território nacional está sujeito a autorização do	INFARMED,	I.P.
2	-	A	autorização de	fabrico é	igualmente exigida para	as	operações de	divisão, acondicionamento,	primário ou secundário,	ou apresentação.....
4	-	Excetuam-se	do	disposto nos números anteriores:







1	-	A	autorização de	fabrico é requerida pela	pessoa singular	ou coletiva que	fabrique ou pretenda fabricar medicamentos no	território nacional.
2	-	Sob	pena de	indeferimento,	o	requerimento:
a)	Especifica os medicamentos a	fabricar e	as	respetivas formas farmacêuticas;
b)	Indica o	local	de	fabrico ou de	controlo;
c)	Assegura o	cumprimento das	exigências técnicas e	legais em matéria de	direção técnica, instalações,	equipamentos e	possibilidades de	controlo;
d)	Identifica o	diretor técnico.
3	-	A	autorização só é concedida se	o	requerente dispuser de	instalações devidamente licenciadas e	de	equipamentos adequados,	com	as	características estabelecidas na
legislação aplicável,	cumprindo as	boas	práticas de	fabrico previstas na lei.
4	-	Os requisitos previstos nos números anteriores devem estar preenchidos na data	da apresentação do	requerimento,	cabendo ao requerente comprovar os elementos e	
dados
constantes do	requerimento.
5	-	O	cumprimento dos	requisitos referidos no	n.º	3	é confirmado pelos serviços competentes do	INFARMED,	I.P.,	designadamente por via	de	inspeção ou inquérito,	antes	da
decisão de	concessão ou recusa da	autorização
Artigo 60.º
Diretor técnico
1	-	O	titular	de autorização de	fabrico fica obrigado	a	dispor,	de	forma	permanente e efetiva,	de	um	diretor técnico,	que	assume	as	obrigações previstas no	artigo seguinte.
2	-	O	titular	da	autorização pode assumir a	função de	diretor técnico,	desde que	reúna as condições definidas no	presente decreto-lei.































2018 2019 2020 2021 2022 Total
Average	Inventory 185707 246121 272192 272192 272192 1248403
Holding	Costs 12729 17157 19316 19664 20018 88885
Ordering	Costs 69075 70796 71830 73123 74439 359264
Invoice	Issue	Costs 11376 11662 11833 12046 12262 59179
Total 93181 99615 102979 104833 106720 507328
A.2.2.1	Stocks:	Total	Costs of Each Model
SS10
2018 2019 2020 2021 2022 Total
Average	Inventory 287765 392518 437144 437144 437144 1991714
Holding	Costs 19725 27363 31022 31581 32149 141840
Ordering	Costs 40187 39548 39640 40354 41080 200810
Invoice	Issue	Costs 6620 6518 6535 6653 6772 33098
Total 66532 73429 77198 78587 80002 375749
SS	2
2018 2019 2020 2021 2022 Total
Average	Inventory 150613 198896 217322 217322 217322 1001474
Holding	Costs 10324 13865 15422 15700 15983 71294
Ordering	Costs 91609 95148 97298 99050 100833 483938
Invoice	Issue	Costs 15084 15669 16024 16312 16606 79694
Total 117017 124682 128744 131062 133421 634926
AS	IS
2018 2019 2020 2021 2022 Total
Average	Inventory 1058369 1383981 1542371 1542371 1542371 7069464
Holding	Costs 72547 96479 109456 111426 113432 503339
Ordering	Costs 50220 66787 75770 77134 78522 348432
Invoice	Issue	Costs 8260 10984 12462 12686 12915 57307
Total 131026 174250 197687 201246 204868 909078
A.2.2.1	Stocks:	Total	Costs of Each Model
EOQ	Safe
2018 2019 2020 2021 2022 Total
Average	Inventory 690652 730296 532525 532525 532525 3018523
Holding	Costs 46274 48849 35787 35787 35787 202483
Ordering	Costs 13098 15634 16638 16638 16638 78647
Invoice	Issue	Costs 2156 2573 2739 2739 2739 12946
Total 61528 67057 55164 55164 55164 294077
EOQ	Linear
2018 2019 2020 2021 2022 Total
Average	Inventory 266734 309820 326270 326270 326270 1555364
Holding	Costs 17978 20882 21991 21991 21991 104832
Ordering	Costs 13108 15647 16652 16652 16652 78711
Invoice	Issue	Costs 2158 2575 2741 2741 2741 12956
Total 33244 39104 41383 41383 41383 196498
EOQ		non	Linear	99%
2018 2019 2020 2021 2022 Total
Average	Inventory 432320 501158 532525 532525 532525 2531054
Holding	Costs 29067 33685 35787 35787 35787 170112
Ordering	Costs 13098 15634 16638 16638 16638 78647
Invoice	Issue	Costs 2156 2573 2739 2739 2739 12946
Total 44321 51892 55164 55164 55164 261706
EOQ	non	Linear	95%
2018 2019 2020 2021 2022 Total
Average	Inventory 408552 473112 497570 497570 497570 2374374
Holding	Costs 27482 31818 33459 33459 33459 159675
Ordering	Costs 13098 15634 16638 16638 16638 78647
Invoice	Issue	Costs 2156 2573 2739 2739 2739 12946
Total 42736 50025 52836 52836 52836 251268
A.2.2.1	Stocks:	Total	Costs of Each Model
Total	costs	segmented	per	activity	(€)
AS	IS SS2 SS4 SS10 EOQ EOQ	95% EOQ	99% EOQ	Safe
Holding	Costs 503339 71294 88885 141840 104832 159675 170112 202483
Ordering	Costs 348432 483938 359264 200810 78711 78647 78647 78647
Invoice	Issue	Costs 57307 79694 59179 33098 12956 12946 12946 12946











2018 2019 2020 2021 2022 Total
AS	IS 131026 174250 197687 201246 204868 909078
SS2 117017 124682 128744 131062 133421 634926
SS4 93181 99615 102979 104833 106720 507328
SS10 66532 73429 77198 78587 80002 375749
EOQ	L 33244 39104 41383 41383 41383 196498
EOQ	95% 42736 50025 52836 52836 52836 251268
EOQ	99% 44321 51892 55164 55164 55164 261706
EOQ	Safe 61528 67057 55164 55164 55164 294077
A.2.2.1	Stocks:	Average Value in	Stock	and Number of Orders
Average	value	in	stock	in	each	year	(€) Average	holding	cost	in	each	year	(€)
Stock Safety	Stock Stock Safety	Stock
AS	IS 1413893 0 95296 0
SS2 143394 51352 9665 3461
SS4 137524 101205 9269 6821
SS10 117951 253013 7950 17053
EOQ 311073 0 20966 0
EOQ	95% 311073 163802 20966 11040
EOQ	99% 311073 195138 20966 13152
EOQ	Safe 311073 292632 20966 19723
Average	value	in	stock	(€)
2018 2019 2020 2021 2022 Total
AS	IS 1058369 1383981 1542371 1542371 1542371 1413893
SS2 150613 198896 217322 217322 217322 200295
SS4 185707 246121 272192 272192 272192 249681
SS10 287765 392518 437144 437144 437144 398343
EOQ	Linear 266734 309820 326270 326270 326270 311073
EOQ	95% 408552 473112 497570 497570 497570 474875
EOQ	99% 432320 501158 532525 532525 532525 506211
EOQ	S 690652 730296 532525 532525 532525 603705
Number	of	orders
2018 2019 2020 2021 2022 Total
AS	IS 18920 24740 27572 27572 27572 126376
SS2 34513 35247 35406 35406 35406 175977
SS4 26023 26226 26138 26138 26138 130664
SS10 15140 14650 14425 14425 14425 73064
EOQ	
Linear 4257 5077 5395 5395 5395 25518
EOQ	95% 4257 5077 5395 5395 5395 25518
EOQ	99% 4257 5077 5395 5395 5395 25518
EOQ	Safe 4257 5077 5395 5395 5395 25518




























































2018 2019 2020 2021 2022 Total
Technical	Director 20883 21238 21620 22009 22405 108156
Pharmacist 17364,8 17660 17977 18301 18630 89935
Pharmacy	Technician 11158,48 11348 11552 11760 11972 57791
Medical	Assistant 5579,24 5674 5776 5880 5986 28895
Total	costs	and	savings	(€)
2018 2019 2020 2021 2022 Total
AS	IS 471	496 549	514 570958 587115 609	655 2	788	739
TO	BE	without		synergy 481	221 548	055 569473 579724 590	159 2	768	633
TO	BE	with	synergy 470	062 542	381 557921 573844 584	173 2	728	381
Savings 1	434 7	132 13	037 13	272 25	483 60	358
Provided by Financial	Department of JMS
A.2.2.2	FTE’s:	Total	Costs
2018 2019 2020 2021 2022
Costs	RH,	AS	IS
Technical	Director 41766 42476 43241 44019 44811
Pharmaceutical 312566 370860 377536 384331 391249
Pharmacy	Technician 11158 11348 11552 11760 11972
Medical	Assistant 106006 124830 138629 147005 161623
Total 471496 549514 570958 587115 609655
2018 2019 2020 2021 2022
HU 41766 42476 43241 44019 44811
Warehouse 21238 21620 21620 22009 22406
HU 312566 370860 377536 384331 391249
Warehouse 0 0 0 0 0
HU 0 0 0 0 0
Warehouse 11158 11348 11552 11760 11972
HU 55792 62415 69315 70562 71832









Total 470417 542764 557921 573844 584173
2018 2019 2020 2021 2022
HU 41766 42476 43241 44019 44811
Warehouse 20883 21238 21620 22009 22406
HU 312566 370860 377536 384331 391249
Warehouse 0 0 0 0 0
HU 0 0 0 0 0
Warehouse 11158 11348 11552 11760 11972
HU 55792 62415 69315 70562 71832









Total 481221 548056 569473 579724 590159
A.2.2.2	FTE’s:	Times	Measured per	Activity
Number	of	orders	and	medicines	consumed	(Values	acquired	from	"Stocks"	information)
2018 2019 2020 2021 2022
Orders	per	year 8049 9528 10077 10077 10077
Orders	per	day	(6	days	per	week) 26 30 32 32 32
Daily	consumption 11779 12147 17224 19455 19455











A.2.2.2	FTE’s:	Times	Measured per	Activity and Total	Time
Daily	total	time	per	activity	(Seconds)
2018 2019 2020 2021 2022
Reception 9570 11330 11982 11982 11982
Repackaging 24737 25508 36171 40854 40854
Storage 11397 13492 14268 14268 14268
Picking 146663 149925 157688 157688 157688
Total	Picking	time	required	per	day	(Minutes)
2018 2019 2020 2021 2022
UCIP 240,0 270,0 300,0 300,0 300,0
Internment 810,0 832,5 855,0 855,0 855,0
Operating	room 360,0 390,0 420,0 420,0 420,0
Emergency 100,0 112,5 125,0 125,0 125,0
Others 859,4 893,8 928,1 928,1 928,1
Clinics 75,0 62,5 62,5 62,5 62,5
Total	in	Minutes 2444,4 2498,8 2628,1 2628,1 2628,1
Total	in	Hours 40,7 41,6 43,8 43,8 43,8
Nr of	assistants 5,1 5,2 5,5 5,5 5,5
Current	times	of	picking	for	each	service
Time Frequency Number	of	services
Activity Minutes Times	per	day HCIS HCD HCC HCTV HCSant Clinics HCSint HCL HCA
UCIP 60 1 1 1 0,5 0,5 0,5 0 0,5 0,5 0,5
Internment 45 1 8 8 0,5 0,5 0,5 0 0,5 0,5 0,5
Operating	room 60 1 2 2 0,5 0,5 0,5 0 0,5 0,5 0,5
Emergency 25 1 1 1 0,5 0,5 0,5 0 0,5 0,5 0,5
Others 25 0,5 27 27 6,5 2 3,5 0 2,75 2,75 2,75
Clinics 25 0,5 0 0 0 0 0 6 0 0 0


























































2018 2019 2020 2021 2022
Daily	time	in	each	warehouse	activity	(h)







The recommended ratio to a decentralized pharmacy (pharmacist in the HU) is one pharmacist per clinical service,
or 60 beds of ambulatory or low complexity care (counting hospitalization, intensive and intermediate care units,
oncology, urgency and SO)
There should be one pharmacist allocated to the operating room.
For sterile formulations, there should be 3 oncology pharmacists and 2 for other sterile and non-sterile
manipulations (validation of medical prescription, manipulation, double-check).














HCIS 148.31 70% 103.82 103.82 - - - -
HCD 162.61 60% 97.57 97.57 97.57 97.57 97.57 97.57
HCT 301.65 60% - - 180.99 180.99 180.99 180.99
HCA 38.5 75% - - - 22 22 22
HCC 26.38 75% 19.79 19.79 19.79 19.79 19.79 19.79
HCSant 65.25 70% 45.68 45.68 45.68 45.68 45.68 45.68
HCTV 57.6 75% 43.2 43.2 43.20 43.20 43.20 43.20
HCSint 49.74 73% - 36.48 36.48 36.48 36.48 36.48
HCLeiria 49.74 73% - - 36.48 36.48 36.48 36.48













































































Nº	Beds Nº	Beds Nº	Beds Nº	Beds Nº	Beds
188 71.44 188 71.44 214 81.32 214 81.32 214 81.320 0 0
145 55.1 145 55.1 - - - - - -0 0 0
- - - - 266 101.08 266 101.08 266 101.080 0 0
30 11.4 30 11.4 30 11.4 30 11.4 30 11.40 0 0
16 6.08 16 6.08 35 13.3 35 13.3 35 13.30 0 0
26 9.88 32 12.16 36 13.68 36 13.68 36 13.680 0 0
- - - - - - 30 11.4 30 11.40 0 0
- - 42 15.96 42 15.96 42 15.96 42 15.96
- - - - 34 12.79 34 12.92 34 12.92
405 153.9 453 172.14 657 249.53 687 261.06 687 261.06































2017 HCD HCIS HCC HCTV HCSant Total
Direct	Costs: Others 1,013.45	€ 473.79	€ 457.39	€ 601.00	€ 0.00	€ 2,545.62	€
Indirect	Costs: Rent 10,691.04	€ 5,278.22	€ 3,015.98	€ 5,662.66	€ 5,069.20	€ 29,717.10	€
Electricity 2,113.84	€ 2,399.18	€ 548.87	€ 1,107.44	€ 1,120.78	€ 7,290.11	€
Water 408.38	€ 455.47	€ 145.26	€ 233.69	€ 243.49	€ 1,486.29	€
Cleaning 2,891.20	€ 3,694.87	€ 465.45	€ 1,032.46	€ 1,286.31	€ 9,370.29	€
Trash 632.75	€ 368.21	€ 194.46	€ 233.80	€ 288.58	€ 1,717.79	€
Security 1,277.47	€ 1,269.39	€ 184.28	€ 276.46	€ 468.56	€ 3,476.16	€
Various	common	center	cost 5,852.85	€ 4,459.23	€ 821.78	€ 1,944.84	€ 814.22	€ 13,892.92	€
2,197.75	€ 1,674.45	€ 308.58	€ 730.29	€ 305.74	€ 5,216.82	€
98 104 20 43 46 310





2017 HCD HCIS HCC HCTV HCSant Average
Direct	Costs: Others 10.39	€ 4.56	€ 23.12	€ 13.91	€ 0.00	€ 10.40	€
Indirect	Costs: Rent 109.58	€ 50.84	€ 152.44	€ 131.08	€ 110.98	€ 110.98	€
Electricity 21.67	€ 23.11	€ 27.74	€ 25.64	€ 24.54	€ 24.54	€
Water 4.19	€ 4.39	€ 7.34	€ 5.41	€ 5.33	€ 5.33	€
Cleaning 29.63	€ 35.59	€ 23.53	€ 23.90	€ 28.16	€ 28.16	€
Trash 6.49	€ 3.55	€ 9.83	€ 5.41	€ 6.32	€ 6.32	€
Security 13.09	€ 12.23	€ 9.31	€ 6.40	€ 10.26	€ 10.26	€
Various	common	center	cost 59.99	€ 42.95	€ 41.54	€ 45.02	€ 17.83	€ 41.46	€
22.53	€ 16.13	€ 15.60	€ 16.90	€ 6.69	€ 15.57	€




2018 HCD HCIS HCC HCTV HCSant HCSintra Total
Direct	Costs: Others 1,030.68	€ 481.84	€ 465.16	€ 611.22	€ 0.00	€ 152.64	€ 2,741.54	€
Indirect	Costs: Rent 10,691.04	€ 5,278.22	€ 3,015.98	€ 5,662.66	€ 5,069.20	€ 1,598.98	€ 31,316.08	€
Electricity 2,149.77	€ 2,439.97	€ 558.20	€ 1,126.27	€ 1,139.83	€ 321.17	€ 7,735.22	€
Water 415.32	€ 463.21	€ 147.72	€ 237.66	€ 247.63	€ 74.54	€ 1,586.09	€
Cleaning 2,940.35	€ 3,757.68	€ 465.45	€ 1,050.01	€ 1,308.17	€ 309.95	€ 9,831.63	€
Trash 643.50	€ 374.47	€ 197.76	€ 237.77	€ 293.49	€ 88.87	€ 1,835.86	€
Security 1,299.19	€ 1,290.97	€ 187.41	€ 281.16	€ 476.53	€ 107.06	€ 3,642.32	€
Various	common	center	cost 5,952.35	€ 4,535.04	€ 835.75	€ 1,977.90	€ 828.06	€ 430.27	€ 14,559.37	€
2,235.12	€ 1,702.92	€ 313.83	€ 742.71	€ 310.94	€ 161.57	€ 5,467.07	€
98 104 20 43 46 36 347
27,357.31	€ 20,324.33	€ 6,187.28	€ 11,927.36	€ 9,673.85	€ 3,245.04	€ 78,715.17	€
2018 HCD HCIS HCC HCTV HCSant HCSintra Average
Direct	Costs: Others 10.56	€ 4.64	€ 23.51	€ 14.15	€ 0.00	€ 12.55	€ 10.90	€
Indirect	Costs: Rent 109.58	€ 50.84	€ 152.44	€ 131.08	€ 110.98	€ 131.50	€ 114.40	€
Electricity 22.03	€ 23.50	€ 28.21	€ 26.07	€ 24.96	€ 26.41	€ 25.20	€
Water 4.26	€ 4.46	€ 7.47	€ 5.50	€ 5.42	€ 6.13	€ 5.54	€
Cleaning 30.14	€ 36.20	€ 23.53	€ 24.31	€ 28.64	€ 25.49	€ 28.05	€
Trash 6.60	€ 3.61	€ 10.00	€ 5.50	€ 6.43	€ 7.31	€ 6.57	€
Security 13.32	€ 12.44	€ 9.47	€ 6.51	€ 10.43	€ 8.80	€ 10.16	€
Various	common	center	cost 61.01	€ 43.68	€ 42.24	€ 45.78	€ 18.13	€ 35.39	€ 41.04	€
22.91	€ 16.40	€ 15.86	€ 17.19	€ 6.81	€ 13.29	€ 15.41	€
































2019 HCD HCIS HCC HCTV HCSant HCL HCSintra HCT Total
Direct	Costs: Others 1,048.20	€ 204.18	€ 473.07	€ 621.61	€ 0.00	€ 388.09	€ 465.70	€ 816.31	€ 4,017.15	€
Indirect	Costs: Rent 10,691.04	€ 2,199.26	€ 3,015.98	€ 5,662.66	€ 5,069.20	€ 3,997.45	€ 4,796.94	€ 8,468.32	€ 43,900.85	€
Electricity 2,186.32	€ 1,033.94	€ 567.69	€ 1,145.42	€ 1,159.21	€ 816.58	€ 979.90	€ 2,444.69	€ 10,333.73	€
Water 422.38	€ 196.29	€ 150.24	€ 241.70	€ 251.84	€ 189.51	€ 227.41	€ 468.07	€ 2,147.43	€
Cleaning 2,990.34	€ 1,592.32	€ 473.36	€ 1,067.86	€ 1,330.41	€ 788.06	€ 945.67	€ 3,561.13	€ 12,749.15	€
Trash 654.44	€ 158.68	€ 201.12	€ 241.81	€ 298.48	€ 225.94	€ 271.13	€ 547.74	€ 2,599.35	€
Security 1,321.27	€ 547.05	€ 190.60	€ 285.94	€ 484.63	€ 272.20	€ 326.64	€ 1,382.47	€ 4,810.80	€
Various	common	center	cost 6,053.53	€ 1,921.72	€ 849.96	€ 2,011.53	€ 842.14	€ 1,093.95	€ 1,312.75	€ 5,620.48	€ 19,706.07	€
2,273.11	€ 721.61	€ 319.16	€ 755.33	€ 316.22	€ 410.78	€ 492.94	€ 2,110.50	€ 7,399.66	€
98 104 20 43 46 36 36 181 564





2019 HCD HCIS HCC HCTV HCSant HCA HCSintra HCT Average
Direct	Costs: Others 10.74	€ 4.72	€ 23.91	€ 14.39	€ 0.00	€ 12.77	€ 12.77	€ 7.73	€ 10.88	€
Indirect	Costs: Rent 109.58	€ 50.84	€ 152.44	€ 131.08	€ 110.98	€ 131.50	€ 131.50	€ 80.21	€ 112.27	€
Electricity 22.41	€ 23.90	€ 28.69	€ 26.51	€ 25.38	€ 26.86	€ 26.86	€ 23.16	€ 25.47	€
Water 4.33	€ 4.54	€ 7.59	€ 5.59	€ 5.51	€ 6.23	€ 6.23	€ 4.43	€ 5.56	€
Cleaning 30.65	€ 36.81	€ 23.93	€ 24.72	€ 29.13	€ 25.92	€ 25.92	€ 33.73	€ 28.85	€
Trash 6.71	€ 3.67	€ 10.17	€ 5.60	€ 6.53	€ 7.43	€ 7.43	€ 5.19	€ 6.59	€
Security 13.54	€ 12.65	€ 9.63	€ 6.62	€ 10.61	€ 8.95	€ 8.95	€ 13.09	€ 10.51	€
Various	common	center	cost 62.05	€ 44.43	€ 42.96	€ 46.56	€ 18.44	€ 35.99	€ 35.99	€ 53.24	€ 42.46	€
23.30	€ 16.68	€ 16.13	€ 17.48	€ 6.92	€ 13.51	€ 13.51	€ 19.99	€ 15.94	€






















2020 HCD HCC HCTV HCSant HCA HCSintra HCL HCT Total
Direct	Costs: Others 1,067.07	€ 481.59	€ 632.79	€ 0.00	€ 279.42	€ 158.03	€ 470.73	€ 1,424.57	€ 4,514.20	€
Indirect	Costs: Rent 10,691.04	€ 3,015.98	€ 5,662.66	€ 5,069.20	€ 2,827.26	€ 1,598.98	€ 4,762.95	€ 14,517.12	€ 48,145.20	€
Electricity 2,225.67	€ 577.91	€ 1,166.04	€ 1,180.08	€ 587.94	€ 332.51	€ 990.47	€ 4,266.32	€ 11,326.93	€
Water 429.98	€ 152.94	€ 246.05	€ 256.38	€ 136.45	€ 77.17	€ 229.86	€ 816.85	€ 2,345.67	€
Cleaning 3,044.17	€ 481.89	€ 1,087.08	€ 1,354.36	€ 567.40	€ 320.90	€ 955.87	€ 6,214.68	€ 14,026.34	€
Trash 666.22	€ 204.74	€ 246.17	€ 303.85	€ 162.68	€ 92.00	€ 274.05	€ 955.88	€ 2,905.60	€
Security 1,345.05	€ 194.03	€ 291.09	€ 493.35	€ 195.98	€ 110.84	€ 330.16	€ 2,412.61	€ 5,373.12	€
Various	common	center	cost 6,162.50	€ 865.26	€ 2,047.74	€ 857.29	€ 787.64	€ 445.46	€ 1,326.91	€ 9,808.54	€ 22,301.34	€
2,314.03	€ 324.91	€ 768.93	€ 321.92	€ 295.76	€ 167.27	€ 498.26	€ 3,683.13	€ 8,374.20	€
98 20 43 46 22 36 36 181 481





2020 HCD HCC HCTV HCSant HCA HCSintra HCL HCT Average
Direct	Costs: Others 10.94	€ 24.34	€ 14.65	€ 0.00	€ 13.00	€ 13.00	€ 13.00	€ 7.87	€ 12.10	€
Indirect	Costs: Rent 109.58	€ 152.44	€ 131.08	€ 110.98	€ 131.50	€ 131.50	€ 131.50	€ 80.21	€ 122.35	€
Electricity 22.81	€ 29.21	€ 26.99	€ 25.84	€ 27.35	€ 27.35	€ 27.35	€ 23.57	€ 26.31	€
Water 4.41	€ 7.73	€ 5.70	€ 5.61	€ 6.35	€ 6.35	€ 6.35	€ 4.51	€ 5.87	€
Cleaning 31.20	€ 24.36	€ 25.16	€ 29.65	€ 26.39	€ 26.39	€ 26.39	€ 34.34	€ 27.99	€
Trash 6.83	€ 10.35	€ 5.70	€ 6.65	€ 7.57	€ 7.57	€ 7.57	€ 5.28	€ 7.19	€
Security 13.79	€ 9.81	€ 6.74	€ 10.80	€ 9.12	€ 9.12	€ 9.12	€ 13.33	€ 10.23	€
Various	common	center	cost 63.16	€ 43.73	€ 47.40	€ 18.77	€ 36.63	€ 36.63	€ 36.63	€ 54.19	€ 42.15	€
23.72	€ 16.42	€ 17.80	€ 7.05	€ 13.76	€ 13.76	€ 13.76	€ 20.35	€ 15.83	€






















2021 HCD HCC HCTV HCSant HCA HCSintra HCL HCT Total
Direct	Costs: Others 1,086.27	€ 490.25	€ 644.19	€ 0.00	€ 284.45	€ 160.87	€ 479.20	€ 1,450.21	€ 4,595.45	€
Indirect	Costs: Rent 10,691.04	€ 3,015.98	€ 5,662.66	€ 5,069.20	€ 2,827.26	€ 1,598.98	€ 4,762.95	€ 14,517.12	€ 48,145.20	€
Electricity 2,265.73	€ 588.31	€ 1,187.02	€ 1,201.32	€ 598.52	€ 338.50	€ 1,008.29	€ 4,343.12	€ 11,530.82	€
Water 437.72	€ 155.69	€ 250.48	€ 260.99	€ 138.90	€ 78.56	€ 234.00	€ 831.55	€ 2,387.90	€
Cleaning 3,098.96	€ 490.56	€ 1,106.65	€ 1,378.74	€ 577.61	€ 326.67	€ 973.08	€ 6,326.54	€ 14,278.81	€
Trash 678.22	€ 208.43	€ 250.60	€ 309.32	€ 165.60	€ 93.66	€ 278.99	€ 973.09	€ 2,957.90	€
Security 1,369.27	€ 197.52	€ 296.33	€ 502.23	€ 199.51	€ 112.83	€ 336.11	€ 2,456.04	€ 5,469.84	€
Various	common	center	cost 6,273.42	€ 880.84	€ 2,084.60	€ 872.72	€ 801.82	€ 453.48	€ 1,350.79	€ 9,985.10	€ 22,702.77	€
2,355.68	€ 330.76	€ 782.77	€ 327.71	€ 301.09	€ 170.28	€ 507.22	€ 3,749.42	€ 8,524.93	€
98 20 43 46 22 36 36 181 481





2021 HCD HCC HCTV HCSant HCA HCSintra HCL HCT Average
Direct	Costs: Others 11.13	€ 24.78	€ 14.91	€ 0.00	€ 13.23	€ 13.23	€ 13.23	€ 8.01	€ 12.32	€
Indirect	Costs: Rent 109.58	€ 152.44	€ 131.08	€ 110.98	€ 131.50	€ 131.50	€ 131.50	€ 80.21	€ 122.35	€
Electricity 23.22	€ 29.74	€ 27.48	€ 26.30	€ 27.84	€ 27.84	€ 27.84	€ 24.00	€ 26.78	€
Water 4.49	€ 7.87	€ 5.80	€ 5.71	€ 6.46	€ 6.46	€ 6.46	€ 4.59	€ 5.98	€
Cleaning 31.76	€ 24.79	€ 25.62	€ 30.19	€ 26.87	€ 26.87	€ 26.87	€ 34.96	€ 28.49	€
Trash 6.95	€ 10.53	€ 5.80	€ 6.77	€ 7.70	€ 7.70	€ 7.70	€ 5.38	€ 7.32	€
Security 14.03	€ 9.98	€ 6.86	€ 11.00	€ 9.28	€ 9.28	€ 9.28	€ 13.57	€ 10.41	€
Various	common	center	cost 64.30	€ 44.52	€ 48.25	€ 19.11	€ 37.29	€ 37.29	€ 37.29	€ 55.17	€ 42.90	€
24.14	€ 16.72	€ 18.12	€ 7.17	€ 14.00	€ 14.00	€ 14.00	€ 20.72	€ 16.11	€






















2022 HCD HCC HCTV HCSant HCA HCSintra HCL HCT Total
Direct	Costs: Others 1,105.83	€ 499.08	€ 655.78	€ 0.00	€ 289.57	€ 163.77	€ 487.83	€ 1,476.32	€ 4,678.17	€
Indirect	Costs: Rent 10,691.04	€ 3,015.98	€ 5,662.66	€ 5,069.20	€ 2,827.26	€ 1,598.98	€ 4,762.95	€ 14,517.12	€ 48,145.20	€
Electricity 2,306.52	€ 598.90	€ 1,208.39	€ 1,222.94	€ 609.29	€ 344.59	€ 1,026.44	€ 4,421.29	€ 11,738.37	€
Water 445.60	€ 158.50	€ 254.99	€ 265.69	€ 141.40	€ 79.97	€ 238.21	€ 846.52	€ 2,430.88	€
Cleaning 3,154.74	€ 499.39	€ 1,126.57	€ 1,403.55	€ 588.01	€ 332.55	€ 990.59	€ 6,440.42	€ 14,535.83	€
Trash 690.42	€ 212.18	€ 255.11	€ 314.88	€ 168.59	€ 95.34	€ 284.01	€ 990.61	€ 3,011.14	€
Security 1,393.91	€ 201.08	€ 301.66	€ 511.27	€ 203.10	€ 114.87	€ 342.16	€ 2,500.25	€ 5,568.30	€
Various	common	center	cost 6,386.35	€ 896.69	€ 2,122.12	€ 888.43	€ 816.26	€ 461.64	€ 1,375.11	€ 10,164.83	€ 23,111.42	€
2,398.08	€ 336.71	€ 796.86	€ 333.61	€ 306.51	€ 173.35	€ 516.35	€ 3,816.91	€ 8,678.38	€
98 20 43 46 22 36 36 181 481





2022 HCD HCC HCTV HCSant HCA HCSintra HCL HCT Average
Direct	Costs: Others 11.33	€ 25.23	€ 15.18	€ 0.00	€ 13.47	€ 13.47	€ 13.47	€ 8.16	€ 12.54	€
Indirect	Costs: Rent 109.58	€ 152.44	€ 131.08	€ 110.98	€ 131.50	€ 131.50	€ 131.50	€ 80.21	€ 122.35	€
Electricity 23.64	€ 30.27	€ 27.97	€ 26.77	€ 28.34	€ 28.34	€ 28.34	€ 24.43	€ 27.26	€
Water 4.57	€ 8.01	€ 5.90	€ 5.82	€ 6.58	€ 6.58	€ 6.58	€ 4.68	€ 6.09	€
Cleaning 32.33	€ 25.24	€ 26.08	€ 30.73	€ 27.35	€ 27.35	€ 27.35	€ 35.58	€ 29.00	€
Trash 7.08	€ 10.72	€ 5.91	€ 6.89	€ 7.84	€ 7.84	€ 7.84	€ 5.47	€ 7.45	€
Security 14.29	€ 10.16	€ 6.98	€ 11.19	€ 9.45	€ 9.45	€ 9.45	€ 13.81	€ 10.60	€
Various	common	center	cost 65.46	€ 45.32	€ 49.12	€ 19.45	€ 37.97	€ 37.97	€ 37.97	€ 56.16	€ 43.68	€
24.58	€ 17.02	€ 18.45	€ 7.30	€ 14.26	€ 14.26	€ 14.26	€ 21.09	€ 16.40	€







































































ii. Centralized warehouse and purchasing department
iii. Costs Analysis

















































































































































































































2018 2019 2020 2021 2022 5	years
20	860	€ 26	476	€ 27	452	€ 27	550	€ 27	649	€ 129	987	€
28	800	€ 43	200	€ 43	200	€ 43	200	€ 43	200	€ 201	600	€
22	740	€ 34	690	€ 35	315	€ 35	950	€ 36	597	€ 165	293	€







2018 2019 2020 2021 2022 5	years
62	777	€ 82	067	€ 95	124	€ 95	496	€ 95	875	€ 431	340	€
57	600	€ 57	600	€ 57	600	€ 57	600	€ 57	600	€ 288	000	€
34	110	€ 46	254	€ 47	086	€ 47	934	€ 48	797	€ 224	181	€













ii. Centralized warehouse and purchasing department
iii. Costs Analysis































Double	Shelves Simple	Shelves Total Total	€
8 7 15 28	900€								
- - - -0
2 - 2 4	600€										0
2 - 2 4	600€										0
2 - 2 4	600€										0
2 - 2 4	600€										0
2 - 2 4	600€										0
2 - 2 4	600€										0
- - - -0




















ii. Centralized warehouse and purchasing department
iii. Costs Analysis



















1	-	O	fabrico,	total	ou parcial,	de	medicamentos no	território nacional está sujeito a autorização do	INFARMED,	I.P.
2	-	A	autorização de	fabrico é igualmente exigida para	as	operações de	divisão, acondicionamento,	primário ou secundário,	ou apresentação.
....
4	-	Excetuam-se	do	disposto nos números anteriores:






1	-	A	autorização de	fabrico é requerida pela	pessoa singular	ou coletiva que	fabrique ou pretenda fabricar medicamentos no	território nacional.
2	-	Sob	pena de	indeferimento,	o	requerimento:
a)	Especifica os medicamentos a	fabricar e	as	respetivas formas farmacêuticas;
b)	Indica o	local	de	fabrico ou de	controlo;
c)	Assegura o	cumprimento das	exigências técnicas e	legais em matéria de	direção técnica, instalações,	equipamentos e	possibilidades de	controlo;
d)	Identifica o	diretor técnico.
3	-	A	autorização só é concedida se	o	requerente dispuser de	instalações devidamente licenciadas e	de	equipamentos adequados,	com	as	características estabelecidas na
legislação aplicável,	cumprindo as	boas	práticas de	fabrico previstas na lei.
4	-	Os requisitos previstos nos números anteriores devem estar preenchidos na data	da apresentação do	requerimento,	cabendo ao requerente comprovar os elementos e	
dados
constantes do	requerimento.
5	-	O	cumprimento dos	requisitos referidos no	n.º	3	é confirmado pelos serviços competentes do	INFARMED,	I.P.,	designadamente por via	de	inspeção ou inquérito,	antes	da
decisão de	concessão ou recusa da	autorização
Artigo 60.º
Diretor técnico
1	-	O	titular	de autorização de	fabrico fica obrigado	a	dispor,	de	forma	permanente e efetiva,	de	um	diretor técnico,	que	assume	as	obrigações previstas no	artigo seguinte.
2	-	O	titular	da	autorização pode assumir a	função de	diretor técnico,	desde que	reúna as condições definidas no	presente decreto-lei.
3	- As	funções de	diretor técnico são assumidas por farmacêutico especialista em indústria farmacêutica,	inscrito na Ordem dos	Farmacêuticos e	sujeito aos deveres
resultantes do
Decreto-Lei	n.º	288/2001,	de	10	de	novembro,	na redação que	lhe foi conferida pelo
Decreto-Lei	n.º	134/2005,	de	16	de	agosto.






bbb)	«Preparado oficinal»,	qualquer medicamento preparado segundo as	indicações compendiais de	uma farmacopeia ou de	um	formulário oficial,	numa farmácia de	oficina ou
em serviços farmacêuticos hospitalares, destinado a	ser dispensado diretamente aos





1	-	O	fabrico,	total	ou parcial,	de	medicamentos no	território nacional está sujeito a autorização do	INFARMED,	I.P.
2	-	A	autorização de	fabrico é igualmente exigida para	as	operações de	divisão, acondicionamento,	primário ou secundário,	ou apresentação.
....
4	-	Excetuam-se	do	disposto nos números anteriores:
a)	As	operações de	preparação,	divisão,	alteração de	acondicionamento ou apresentação efetuadas em farmácias por farmacêuticos ou outras pessoas legalmente habilitadas,	com vista	
à dispensa de	medicamentos;





1	-	A	autorização de	fabrico é requerida pela	pessoa singular	ou coletiva que	fabrique ou pretenda fabricar medicamentos no	território nacional.
2	-	Sob	pena de	indeferimento,	o	requerimento:
a)	Especifica os medicamentos a	fabricar e	as	respetivas formas farmacêuticas;
b)	Indica o	local	de	fabrico ou de	controlo;
c)	Assegura o	cumprimento das	exigências técnicas e	legais em matéria de	direção técnica, instalações,	equipamentos e	possibilidades de	controlo;
d)	Identifica o	diretor técnico.
3	-	A	autorização só é concedida se	o	requerente dispuser de	instalações devidamente licenciadas e	de	equipamentos adequados,	com	as	características estabelecidas na
legislação aplicável,	cumprindo as	boas	práticas de	fabrico previstas na lei.
4	-	Os requisitos previstos nos números anteriores devem estar preenchidos na data	da apresentação do	requerimento,	cabendo ao requerente comprovar os elementos e	
dados
constantes do	requerimento.
5	-	O	cumprimento dos	requisitos referidos no	n.º	3	é confirmado pelos serviços competentes do	INFARMED,	I.P.,	designadamente por via	de	inspeção ou inquérito,	antes	da
decisão de	concessão ou recusa da	autorização
Artigo 60.º
Diretor técnico
1	-	O	titular	de autorização de	fabrico fica obrigado	a	dispor,	de	forma	permanente e efetiva,	de	um	diretor técnico,	que	assume	as	obrigações previstas no	artigo seguinte.
2	-	O	titular	da	autorização pode assumir a	função de	diretor técnico,	desde que	reúna as condições definidas no	presente decreto-lei.
3	- As	funções de	diretor técnico são assumidas por farmacêutico especialista em indústria farmacêutica,	inscrito na Ordem dos	Farmacêuticos e	sujeito aos deveres
resultantes do
Decreto-Lei	n.º	288/2001,	de	10	de	novembro,	na redação que	lhe foi conferida pelo
Decreto-Lei	n.º	134/2005,	de	16	de	agosto.









ii. Centralized warehouse and purchasing department
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• Study the optimal logistics in the warehouse, in terms of
location of the following areas: reception, storage and
expedition
• Site construction
• Buy and redistribute the equipment for the central warehouse
• Verify security conditions in the central warehouse and secure
temperature and humidity control
• Plan daily schedule of working and opening hours, specific times
for reception and expedition
Preparing	the	Warehouse Main tasks and activities
• Final	decision	on	which	warehouse	to	choose	does	not	
depend	on	the	centralization	of	the	pharmacy









• Get in touch with the chosen distributor
• Meeting with the aim of clarifying the conditions, such as
frequency of delivery, price of distribution and transport
conditions
• Meeting with suppliers, in order to clarify the changes in delivery
location and new delivery schedules
• Negotiation for potential gains, due to less and shorter delivery
routes
• Develop an internal change management plan, in order to
inform the employees of the changes
• Communicate with the employees to understand their
preferences in terms of location, schedules and skills
• Training period for all employees who will be working in the
central warehouse








Transferring	the	activity Main tasks and activities
• Transfer	the	activities	of	middle-sized	hospitals	to	the	central	
warehouse
• Transfer	the	clinics	activities
• Transfer	the	activity	at	HCT	and	HCD
A.5	Implementation	Activities
